Macquarie Group’s Prothena Corp PRTA Stock Holding History

Macquarie Group’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,369	Closed	-$2.35M	–	1688
2023 Q2	$2.35M	Buy	34,369 +5,800	+20%	+$374K	﹤0.01%	1135
2023 Q1	$1.39M	Hold	28,569	–	–	﹤0.01%	1282
2022 Q4	$1.72M	Buy	28,569 +27,702	+3,195%	+$1.62M	﹤0.01%	1251
2022 Q3	$94K	Sell	867 -681	-44%	-$21.5K	﹤0.01%	1784
2022 Q2	$42K	Hold	1,548	–	–	﹤0.01%	2097
2022 Q1	$57	Hold	1,548	–	–	﹤0.01%	2098
2021 Q4	$76K	Hold	1,548	–	–	﹤0.01%	2024
2021 Q3	$110K	Buy	+1,548	New	+$96.1K	﹤0.01%	1955
2014 Q1	–	Sell	-42	Closed	-$1K	–	1576
2013 Q4	$1K	Hold	42	–	–	﹤0.01%	1537
2013 Q3	$1K	Buy	+42	New	+$743	﹤0.01%	1602

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's PRTA Position: Q3 2023 in Review

Macquarie Group sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 34,369 shares — an estimated $2.35M sold.

Macquarie Group first reported a position in PRTA in Q3 2013 and held it in 10 quarters. The position peaked at $2.35M in Q2 2023. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

Macquarie Group reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
Macquarie Group sold 34,369 Prothena Corp shares in Q3 2023, an estimated $2.35M.
Macquarie Group first reported a position in Prothena Corp in Q3 2013 and held it in 10 quarters.
Macquarie Group's Prothena Corp position peaked at $2.35M in Q2 2023.
186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Macquarie Group's 13F filing for Q3 2023, filed 14 Nov 2023.